Form Type and Filing Date: 8-K current report filed by Colgate-Palmolive Company on January 30, 2026, reporting events as of that same date Item 2.02 - Results of Operations and Financial Condition: The filing includes disclosure of results of operations and financial condition information Item 8.01 - Financial Statements and Exhibits: The filing contains financial statements and exhibits related…

Our analysis rates this filing BEARISH. Colgate-Palmolive faces elevated business challenges warranting a HIGH concern level (7.0/10). The material goodwill impairment in the skin health business represents a significant strategic failure, with the 25% EPS decline being a major red flag. The…

Concern level: HIGH (7.0/10). Key factors: Material goodwill and intangible asset impairment in skin health business (severity 9/10) - 25% EPS decline YoY ($2.63 vs $3.51) driven by $0.88/share impairment charge, signaling significant strategic misstep and capital allocation failure; Organic sales growth of only 1.4% indicates weak top-line momentum and limited pricing power for a consumer…

Notable risk changes: Material Impairment Charge: $0.88 per share EPS impact from goodwill/intangible asset impairments in skin health business ($2.63 GAAP EPS vs $3.51 prior year), representing a 25% decline and signaling strategic underperformance; Private Label Pet Volume Weakness: Explicit disclosure of 0.7% negative impact from lower private label pet volume on organic sales, indicating competitive pressure or…

The model predicts CL will outperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.